BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3014110)

  • 1. Effect of food on the bioavailability of lisinopril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Mojaverian P; Rocci ML; Vlasses PH; Hoholick C; Clementi RA; Ferguson RK
    J Pharm Sci; 1986 Apr; 75(4):395-7. PubMed ID: 3014110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ; Drummer OH; Smith HJ; Froomes P; McNeil JJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lisinopril: a new angiotensin-converting enzyme inhibitor.
    Chase SL; Sutton JD
    Pharmacotherapy; 1989; 9(3):120-8; discussion 128-30. PubMed ID: 2547199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ; Jarrott B
    J Pharm Sci; 1986 May; 75(5):512-6. PubMed ID: 3016233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of food on the bioavailability of enalapril.
    Swanson BN; Vlasses PH; Ferguson RK; Bergquist PA; Till AE; Irvin JD; Harris K
    J Pharm Sci; 1984 Nov; 73(11):1655-7. PubMed ID: 6097665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
    Friedman DI; Amidon GL
    J Pharm Sci; 1989 Dec; 78(12):995-8. PubMed ID: 2559191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lisinopril.
    Beermann B
    Am J Med; 1988 Sep; 85(3B):25-30. PubMed ID: 2844083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.
    Till AE; Dickstein K; Aarsland T; Gomez HJ; Gregg H; Hichens M
    Br J Clin Pharmacol; 1989 Feb; 27(2):199-204. PubMed ID: 2540786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisinopril: a new angiotensin-converting enzyme inhibitor.
    Armayor GM; Lopez LM
    Drug Intell Clin Pharm; 1988 May; 22(5):365-72. PubMed ID: 2839326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers.
    Beermann B; Till AE; Gomez HJ; Hichens M; Bolognese JA; Junggren I
    Biopharm Drug Dispos; 1989; 10(4):397-409. PubMed ID: 2547465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F; Henriksen JH
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA; Cutler RE; Parmer RJ; Ford NF
    Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteers.
    Vandenburg MJ; Morris F; Marks C; Kelly JG; Dews IM; Stephens JD
    Xenobiotica; 1988 Oct; 18(10):1179-84. PubMed ID: 2853897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril pharmacokinetics in chronic renal failure.
    Jackson B; Cubela RB; Conway EL; Johnston CI
    Br J Clin Pharmacol; 1988 Jun; 25(6):719-24. PubMed ID: 2849471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
    Thwaites DT; Cavet M; Hirst BH; Simmons NL
    Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man.
    Nussberger J; Brunner DB; Waeber B; Biollaz J; Brunner HR
    Clin Sci (Lond); 1987 Mar; 72(3):387-9. PubMed ID: 3028701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide.
    Swaisland AJ
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():69-71. PubMed ID: 1665181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.